Q & A with the Early Drug Discovery Unit’s new director

17 Jan 2022

We spoke to Tom Durcan about his new position, the role of stem cells in disease research and some exciting new developments at the EDDU.

Ramping up research

6 Jul 2020

Restrictions on research are gradually being lifted at The Neuro, but the effects of the pandemic will be felt for a long time.

Passion for science leads Rhalena Thomas to The Neuro to find a cure for Parkinson's disease

20 Dec 2019

Dr. Rhalena Thomas is an HBHL Postdoctoral Fellow who uses computational biology to study genes implicated in Parkinson’s disease.

Thomas Durcan receives first ever Reitman prize

6 Dec 2019

Foundational award will go to researchers who have shown impactful and open scientific practices

Thomas Durcan uses Open Science to make his work accessible and intelligible

26 Sep 2019

His efforts are centered on the belief that Open Science can make the research endeavour more efficient and transparent

Why I'm giving my data away

9 Jul 2019

There hasn't been a breakthrough in Parkinson's research since the 1960s. That’s why Thomas Durcan is making his lab's methods available to anyone who wants them.

Opening science for patients

3 Jul 2019

Ben Stecher thinks researchers have a moral obligation to share data

$4M for open science drug screening

4 Jun 2019

Funds will support development of precision therapies for ALS and Parkinson’s disease

Pages

OPEN SCIENCE EVENTS

There are currently no events available.

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram x, formerly known as twitter linkedIn youtube

Back to top